About Graviti Biotech
Graviti Biotech is a Healthcare company. Pharmaceutical development and supply of medicines in healthcare sectors. The company has 1 employees. Its Indian entity Graviti Biotech Private Limited reported revenue of ₹62.7 Lakh. Graviti Biotech offers products and services including Anti Bacterial and Anti Fungal. Its focus areas include Medical Services, Supportive Therapy, Pediatric and Gynecology Medicines and Pharmaceuticals.
Company details
Graviti Biotech is identified as a pharmaceutical company that was established in 2015, with a focus on the development of innovative therapies and formulations in anti-infectives, antifungal treatments, and supportive therapies. It is noted for adhering to global standards of quality, safety, and environmental practices, including zero-discharge processes. The company is recognized for providing consistent supplies of medicines across India, emphasizing affordability and accessibility in areas like pediatrics, gynecology, and urology. Operations are conducted from Bangalore, where safe disposal of waste is ensured, and products are manufactured under strict WHO guidelines to meet health needs.
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gravitibiotech.com
- Legal Name Graviti Biotech Pvt Ltd
- Date of Incorporation 19 Feb, 2021
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹62.7 Lakh
FY 2025 · -15% YoY
- Indian entity net profit₹1.6 Lakh
FY 2025 · 3% margin
- Indian entity EBITDA₹2.7 Lakh
FY 2025 · 4% margin
- Employee Count1
Associated legal entities of Graviti Biotech
Graviti Biotech operates through Graviti Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Graviti Biotech Private Limited CIN U24302KA2021PTC144380 | Active | 19 Feb 2021 | Bangalore, Karnataka | ₹0.6 Cr | 2 | View details |
Products & Services of Graviti Biotech
Graviti Biotech offers a comprehensive portfolio of products and services, including Anti Bacterial and Anti Fungal.
Anti-bacterial medicines are developed and supplied for treating infections
Anti-fungal medicines are developed and supplied for managing fungal conditions
Board of directors of Graviti Biotech Private Limited (Graviti Biotech)
Graviti Biotech Private Limited is the primary company behind Graviti Biotech. The board of Graviti Biotech Private Limited currently have 2 directors; the longest-serving is Santwana Dhakal, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Santwana Dhakal DIN 09073857 | Director | 19 Feb 2021 | 5 yrs 8 mo | Graviti Biotech Private Limited |
| Arshid Gani DIN 07795999 | Director | 19 Feb 2021 | 5 yrs 8 mo | Graviti Biotech Private Limited |
Financials of Graviti Biotech
Figures of Graviti Biotech Private Limited, the primary company behind Graviti Biotech, for FY 2025. Revenue was ₹62.7 Lakh (-15% year on year). Net profit was ₹1.6 Lakh (3% margin). EBITDA was ₹2.7 Lakh (4% margin). Revenue has grown at a compounded annual rate of -2% over three years.
- ₹62.7 LakhRevenue · FY 2025 · -15% YoY
- ₹1.6 LakhNet profit · 3% margin
- ₹2.7 LakhEBITDA · 4% margin
- ₹1 LakhPaid-up capital
- -2%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Graviti Biotech Private Limited are on its company page.
Detailed financial statements for Graviti Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Graviti Biotech
Graviti Biotech has 1 employees.
The primary company behind Graviti Biotech, Graviti Biotech Private Limited, reported revenue of ₹62.7 Lakh for FY 2025, down 15% year on year.
Graviti Biotech is identified as a pharmaceutical company that was established in 2015, with a focus on the development of innovative therapies and formulations in anti-infectives, antifungal treatments, and supportive therapies. It is noted for adhering to global standards of quality, safety, and environmental practices, including zero-discharge processes. The company is recognized for providing consistent supplies of medicines across India, emphasizing affordability and accessibility in areas like pediatrics, gynecology, and urology. Operations are conducted from Bangalore, where safe disposal of waste is ensured, and products are manufactured under strict WHO guidelines to meet health needs.
Graviti Biotech offers Anti Bacterial and Anti Fungal.
Graviti Biotech operates through Graviti Biotech Private Limited.
The legal entities of Graviti Biotech currently have 2 directors, including Santwana Dhakal, Arshid Gani.